# Neodolpasse® Infusion Solution Versus Diclofenac 75 mg Infusion in the Treatment of Postoperative Pain After Elective Knee Surgery

> **NCT03493490** · PHASE4 · COMPLETED · sponsor: **Medical University of Vienna** · enrollment: 72 (actual)

## Conditions studied

- Pain, Postoperative
- Analgesic Adverse Reaction
- Cruciate Ligament Rupture

## Interventions

- **DRUG:** Neodolpasse
- **DRUG:** Diclofenac
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03493490
- **Lead sponsor:** Medical University of Vienna
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-01
- **Primary completion:** 2019-05-31
- **Final completion:** 2019-05-31
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2023-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03493490

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03493490, "Neodolpasse® Infusion Solution Versus Diclofenac 75 mg Infusion in the Treatment of Postoperative Pain After Elective Knee Surgery". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT03493490. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*